Community Healthcare Trust Inc CHCT
We take great care to ensure that the data presented and summarized in this overview for Community Healthcare Trust Inc is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CHCT
View all-
Black Rock Inc. New York, NY4.67MShares$74.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.75MShares$43.8 Million0.0% of portfolio
-
Systematic Financial Management LP Teaneck, NJ1.04MShares$16.6 Million0.56% of portfolio
-
Macquarie Group LTD Australia, C31.03MShares$16.4 Million0.02% of portfolio
-
State Street Corp Boston, MA960KShares$15.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA700KShares$11.2 Million0.0% of portfolio
-
Mirae Asset Global Etfs Holdings Ltd. Central, K3681KShares$10.9 Million0.03% of portfolio
-
Invesco Ltd. Atlanta, GA677KShares$10.8 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL670KShares$10.7 Million0.0% of portfolio
-
Nuveen, LLC Charlotte, NC644KShares$10.3 Million0.0% of portfolio
Latest Institutional Activity in CHCT
Top Purchases
Top Sells
About CHCT
Community Healthcare Trust Incorporated is a real estate investment trust that focuses on owning income-producing real estate properties associated primarily with the delivery of outpatient healthcare services in our target sub-markets throughout the United States. The Company had investments of approximately $667.3 million in 131 real estate properties as of September 30, 2020, located in 33 states, totaling approximately 2.8 million square feet.
Insider Transactions at CHCT
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 30
2025
|
William G. Iv Monroe Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
650
-0.43%
|
$10,400
$16.77 P/Share
|
Jun 30
2025
|
Leigh Ann Stach Executive Vice President & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
604
-0.14%
|
$9,664
$16.77 P/Share
|
Jun 30
2025
|
David H. Dupuy CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,052
-0.23%
|
$16,832
$16.77 P/Share
|
Jun 02
2025
|
William G. Iv Monroe Executive Vice President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
7,000
+4.45%
|
-
|
May 28
2025
|
R. Lawrence Van Horn Director |
BUY
Open market or private purchase
|
Direct |
11,815
+11.78%
|
$189,040
$16.37 P/Share
|
May 15
2025
|
Cathrine Cotman Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,250
+15.67%
|
$100,000
$16.64 P/Share
|
May 15
2025
|
Robert Z Hensley Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,250
+6.97%
|
$100,000
$16.64 P/Share
|
May 15
2025
|
Claire M Gulmi Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,933
+12.23%
|
$126,928
$16.64 P/Share
|
May 15
2025
|
Alan Gardner Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,865
+14.9%
|
$253,840
$16.64 P/Share
|
May 15
2025
|
R. Lawrence Van Horn Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,933
+9.37%
|
$126,928
$16.64 P/Share
|
May 13
2025
|
David H. Dupuy CEO and President |
BUY
Open market or private purchase
|
Direct |
10,000
+2.13%
|
$160,000
$16.23 P/Share
|
May 01
2025
|
R. Lawrence Van Horn Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,524
+8.67%
|
-
|
May 01
2025
|
Robert Z Hensley Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,524
+7.79%
|
-
|
May 01
2025
|
Claire M Gulmi Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,524
+11.75%
|
-
|
May 01
2025
|
Alan Gardner Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,524
+8.02%
|
-
|
May 01
2025
|
Cathrine Cotman Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,524
+19.24%
|
-
|
Apr 30
2025
|
Cathrine Cotman Director |
SELL
Open market or private sale
|
Direct |
3,000
-12.57%
|
$51,000
$17.09 P/Share
|
Apr 30
2025
|
Cathrine Cotman Director |
BUY
Open market or private purchase
|
Direct |
3,000
+11.17%
|
$51,000
$17.1 P/Share
|
Jan 15
2025
|
David H. Dupuy CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
26,275
+5.53%
|
$499,225
$19.03 P/Share
|
Jan 15
2025
|
William G. Iv Monroe Executive Vice President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
25,981
+15.34%
|
$493,639
$19.03 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 344K shares |
---|---|
Open market or private purchase | 55.8K shares |
Payment of exercise price or tax liability | 10.6K shares |
---|---|
Open market or private sale | 3K shares |